Φορτώνει......
Intermediate hepatocellular carcinoma: the role of transarterial therapy
According to Barcelona Clinic Liver Cancer, the recommended first-line treatment for patients with intermediate stage of hepatocellular carcinoma (HCC) is transarterial chemoembolization. Patients with intermediate stage of HCC represent 20% with a 2-year survival of approximately 50%. Nowadays, tra...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Hepat Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Future Medicine Ltd
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4792112/ https://ncbi.nlm.nih.gov/pubmed/26998220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep.15.32 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|